2
Orphan Designations
0
FDA Approvals
6
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| acute graft versus host disease | ProTmune (ex vivo Programmed Mobilized Peripheral Blood) | Orphan Designation | - |
| chronic graft versus host disease | ProTmune (ex vivo Programmed Mobilized Peripheral Blood) | Orphan Designation | - |
| graft versus host disease | ProTmune (ex vivo Programmed Mobilized Peripheral Blood) | Orphan Designation | - |
| human T-lymphotropic virus 1 infectious disease | allogeneic cord blood cells, ex vivo modulated with 16,16 dimethyl prostaglandin E2 (dmPGE2) | Orphan Designation | - |
| human granulocytic anaplasmosis | allogeneic cord blood cells, ex vivo modulated with 16,16 dimethyl prostaglandin E2 (dmPGE2) | Orphan Designation | - |
| human papillomavirus-related squamous cell carcinoma | allogeneic cord blood cells, ex vivo modulated with 16,16 dimethyl prostaglandin E2 (dmPGE2) | Orphan Designation | - |